Frustrating providers, frustrating patients. While there is a lot of media attention on these medications as part of the solution, they are not new
AminoMultiPlex injection appointments are easy to schedule and fit seamlessly into active routines
This breakthrough allows us to serve millions of patients nationwide with the reliable, life-changing treatments they need for decades to come
In 2024, data from the SURMOUNT-5 trials for tirzepatide were submitted for moderate-to-severe obstructive sleep apnea and obesity and heart failure with preserved ejection fraction and obesity to the U.S
When patients have multi-site injuries, accumulated wear and tear, or chronic inflammation that affects more than one area, BPC-157 alone may not be enough
Clinical research shows that many individuals lose 10-15% of their starting body weight, and some may lose even more with consistent use and lifestyle support